The Basics: Understanding Malignant Peritoneal Mesothelioma

Being diagnosed with Malignant Peritoneal Mesothelioma (MPM) can feel overwhelming, especially because it is an exceptionally rare cancer. It affects only about one person in every million worldwide each year ^[1]. While most people associate mesothelioma with the lungs, MPM begins in the peritoneum, which is the thin, protective lining that surrounds your abdominal organs ^[1].

How MPM Develops

The disease starts in the mesothelial cells that make up the peritoneum. These cells normally produce a small amount of lubricating fluid to help your organs move smoothly. In MPM, these cells undergo genetic changes that cause them to grow uncontrollably ^[1].

Unlike many other cancers that form a single, solid tumor, MPM often spreads through a process called exfoliation ^[1]. Small groups of cancer cells break off and travel through the natural fluid in your abdomen, “seeding” or planting themselves on the surfaces of various organs. This diffuse growth pattern is one reason why the disease can be difficult to detect on standard imaging like CT scans in its earliest stages ^[1].

Understanding the Causes: Asbestos and Genetics

While asbestos exposure is the most famous cause of mesothelioma, the connection is different for the peritoneal (abdominal) type than for the pleural (lung) type.

• Asbestos Exposure: Approximately 30% to 50% of MPM cases are linked to asbestos ^[1]. Microscopic fibers can be inhaled or swallowed, eventually migrating to the abdominal lining and causing chronic inflammation that leads to cancer decades later.
• Genetics and BAP1 Mutations: Genetics play a significantly larger role in MPM than previously understood. It is important to distinguish between mutations that are only in the tumor versus ones you were born with.
  • Somatic Mutations (Tumor-only): The BAP1 gene is the most common molecular alteration, found to be mutated in the cancer cells of about 50% of all MPM patients ^[1]. This acquired change is not passed down to children.
  • Germline Mutations (Inherited): A smaller portion, about 17% of patients, carry an inherited genetic change, with the inherited BAP1 gene mutation being the most common culprit (7% of cases) ^[1]. If you have this inherited mutation, you may have a higher risk of other cancers, such as melanoma or kidney cancer, and your family members may also be at risk ^[1]. Your doctor will help determine if you need testing to see if your mutation is somatic or germline.

Why Misdiagnosis is Common

Because MPM is so rare, it is frequently mistaken for more common conditions. Most patients experience a prolonged diagnostic process before reaching the correct conclusion.

• Non-Specific Symptoms: The most common early signs are ascites (fluid buildup causing abdominal swelling) and abdominal pain ^[1]. These are often initially dismissed as Irritable Bowel Syndrome (IBS), or in women, mistaken for ovarian cancer.
• Pathology Challenges: Under a microscope, MPM cells can look remarkably similar to other abdominal cancers. Doctors must use a specialized process called immunohistochemistry (IHC)—using specific proteins like Calretinin and WT1 as “markers”—to confirm the diagnosis and distinguish it from other malignancies ^[1].

What to Expect Initially

Because this disease is rare, your care should ideally involve a multidisciplinary team of specialists familiar with current guidelines, like the “Chicago Consensus” ^[1]. These guidelines emphasize that because MPM behaves differently than other cancers, it requires a tailored approach that may include specialized surgery, localized chemotherapy, or newer immunotherapy options ^[1]. Knowing that your diagnosis is confirmed through expert pathology is the first critical step in navigating your care.